Evidence map›Paper›PMID 37630386›Full record

ArticleMolecules (Basel, Switzerland)2023

cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T

Shengchao Wang, Guiqiang Qi, Zhichen Zhang, Qiangqiang Yin, Na Li, Zhongtao Li, Guangyue Shi, Haifeng Hu, Liguo Hao

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. TargetedImmunotherapy advances · 2026
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shengchao WangDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.ORCID 0000-0002-0921-0632
Guiqiang QiDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Zhichen ZhangDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Qiangqiang YinDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Na LiDepartment of Imaging Medicine and Nuclear Medicine, School of Clinical Medicine, Jiamusi University, Jiamusi 154002, China.
Zhongtao LiDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Guangyue ShiDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Haifeng HuMedical Imaging Center, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.
Liguo HaoDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.ORCID 0000-0001-6102-4493
Qiqihar Medical University · CNJiamusi University · CN

Funding

The Health Commission of Heilongjiang Province No.20210909010355The Qiqihar Medical University Postgraduate Innovation Fund Project No. QYYCX2022-03
6 · The paper itself

Abstract

Clinically, magnetic resonance imaging (MRI) often uses contrast agents (CAs) to improve image contrast, but single-signal MRI CAs are often susceptible to calcification, hemorrhage, and magnetic sensitivity. Herein, iron acetylacetone and gadolinium acetylacetone were used as raw materials to synthesize a T

Indexed as

Pancreatic NeoplasmsPrecision MedicineDocetaxelGadoliniumHumansIronMagnetic Resonance ImagingPentanonesTumor MicroenvironmentacetylacetoneDocetaxelGadoliniumgadolinium oxideIronPentanonesperferryl irondrug deliveryDTXMRIpancreatic cancerT1–T2

Identifiers

PMID37630386
PMCPMC10459307
OpenAlexW4386027188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.